RESTASIS MULTIDOSE vs RYSTIGGO

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 20, 2026·How we rate

Possible drug interaction. RESTASIS MULTIDOSE and RYSTIGGO are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	RESTASIS MULTIDOSE	RYSTIGGO
Rating	72/100	70/100
Pharmacy pays	~$52.85 /30	—
Type	RX	RX
Active ingredient	CYCLOSPORINE	ROZANOLIXIZUMAB-NOLI
Manufacturer	Abbvie	Ucb Inc
Dosage forms	Emulsion	Injectable
Drug class	Calcineurin Inhibitor Immunosuppressant	—
Boxed warning	None	None
Half-life	about 8.4 hours (range 5 to 18 hours)	—
Treats	Rheumatoid Arthritis, Focal Segmental Glomerulosclerosis, Systemic Lupus Erythematosus	Myasthenia Gravis

restasis multidose rystiggo

Rating

72/100

70/100

Pharmacy pays

~$52.85 /30

—

Type

Active ingredient

CYCLOSPORINE

ROZANOLIXIZUMAB-NOLI

Manufacturer

Abbvie

Ucb Inc

Dosage forms

Emulsion

Injectable

Drug class

Calcineurin Inhibitor Immunosuppressant

—

Boxed warning

None

Half-life

about 8.4 hours (range 5 to 18 hours)

—

Treats

Rheumatoid Arthritis, Focal Segmental Glomerulosclerosis, Systemic Lupus Erythematosus

Myasthenia Gravis

Frequently asked questions

Which is better-rated, Restasis Multidose or Rystiggo?

By our independent rating, Restasis Multidose scores higher — 3.6 vs 3.5 out of 5 for Rystiggo. Ratings are based on FDA regulatory (recall-safety) data.

What is the difference between Restasis Multidose and Rystiggo?

Restasis Multidose contains Cyclosporine, while Rystiggo contains Rozanolixizumab-Noli — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.